APA (7th ed.) Citation

Peng, F., Chai, D., Xu, C., Lin, L., Zhang, M., & Lin, J. (2018). VDR Agonist Prevents Diabetic Endothelial Dysfunction through Inhibition of Prolyl Isomerase-1-Mediated Mitochondrial Oxidative Stress and Inflammation. Oxidative medicine and cellular longevity, 2018(2018), 1-13. https://doi.org/10.1155/2018/1714896

Chicago Style (17th ed.) Citation

Peng, Feng, Dajun Chai, Chang-Sheng Xu, Liming Lin, Meijin Zhang, and Jinxiu Lin. "VDR Agonist Prevents Diabetic Endothelial Dysfunction Through Inhibition of Prolyl Isomerase-1-Mediated Mitochondrial Oxidative Stress and Inflammation." Oxidative Medicine and Cellular Longevity 2018, no. 2018 (2018): 1-13. https://doi.org/10.1155/2018/1714896.

MLA (9th ed.) Citation

Peng, Feng, et al. "VDR Agonist Prevents Diabetic Endothelial Dysfunction Through Inhibition of Prolyl Isomerase-1-Mediated Mitochondrial Oxidative Stress and Inflammation." Oxidative Medicine and Cellular Longevity, vol. 2018, no. 2018, 2018, pp. 1-13, https://doi.org/10.1155/2018/1714896.